Sign in
4

Changes in Ownership

ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0001931826-22-000002

Options or other derivatives

  • CFO, Secretary, Treasurer acquired 900,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Chen Robert C J CFO, Secretary, Treasurer 2022-05-16 Grant or award · Options +900,000 $0.04 $36,000 900,000 D
Loading xslF345X03/primary_doc.xml…